Mink TherapeuticsINKT
13F holders, Q4 2025 (December 31)1holders
1new positions
0sold out
$11.15avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Mink Therapeutics Inc. (INKT) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 0 sold out. The largest holder was Horizon Financial Services, LLC ($2K).
- Company
- Mink Therapeutics Inc.
- Filed as
- INKT (Q4 2025)
- CUSIP
- 603693102
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q4 2025: 160 shares bought, net +160 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Horizon Financial Services, LLC | 0.00% | New | 160 | $2K |
"% of holder's portfolio" is INKT's weight in each manager's 13F, not the share of Mink Therapeutics Inc. the manager owns.